Why did BTLS.BR stock drop pre-market today?

BTLS.BR stock fell 15.46% pre-market on Feb 10, 2026 after heavy selling pushed shares to the day low €2.51. Volume spiked to 182,928 shares, suggesting accelerated selling and profit-taking ahead of upcoming earnings and product-readout catalysts.

What is Meyka AI's forecast for BTLS.BR stock?

Meyka AI's forecast model projects monthly €2.40, quarterly €2.83, and yearly €5.62. The yearly figure implies about 118.68% upside from the current €2.57. Forecasts are model-based projections and not guarantees.

What are key risks for investors in BTLS.BR stock?

Key risks include persistent net losses, a high price-to-sales ratio, limited liquidity, and trial or regulatory setbacks. A confirmed close below €2.50 would increase downside risk and may trigger further selling.

Where can I find official Biotalys news and company updates?

Official updates are available on the Biotalys website and the company LinkedIn page. Check [Biotalys website](https://www.biotalys.com) and [Biotalys LinkedIn](https://www.linkedin.com/company/biotalys-nv/) for filings and trial-readout notices.

EU Stocks

Pre-market top loser Feb 2026: BTLS.BR Biotalys EURONEXT down 15.46% watch €2.51 support

ByDanny Kontos February 10, 2026February 10, 2026

BTLS.BR stock plunged 15.46% pre-market to €2.57 on Feb 10, 2026 after heavy selling pushed the share to a day low of €2.51. Volume jumped to 182,928 shares, nearly four times the average, signalling accelerated outflows on EURONEXT in Europe. The move puts Biotalys NV (BTLS.BR) well below its 50-day average of €3.67 and the 200-day average of €4.27, and frames today’s decline as a short-term technical break with mixed fundamental context.